Stopped: New study design and data collection needed
The purpose of this study is to confirm long-term clinical safety and performance, acceptability of identified risks, and detect emerging risks based on factual evidence for the PROPEL family of products when used according to labeling in a real-world setting.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
To characterize the SNOT-22 total score change from baseline to Month 6 in patients with CRS undergoing FESS
Timeframe: From baseline (prior to FESS procedure and sinus implant) to 6 months post procedure